Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Return on Equity (2017 - 2025)

Historic Return on Equity for Rocket Pharmaceuticals (RCKT) over the last 10 years, with Q3 2025 value amounting to 0.74%.

  • Rocket Pharmaceuticals' Return on Equity rose 100.0% to 0.74% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.74%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.56% for FY2024, which is 400.0% down from last year.
  • Per Rocket Pharmaceuticals' latest filing, its Return on Equity stood at 0.74% for Q3 2025, which was up 100.0% from 0.69% recorded in Q2 2025.
  • Over the past 5 years, Rocket Pharmaceuticals' Return on Equity peaked at 0.31% during Q1 2021, and registered a low of 0.75% during Q3 2024.
  • In the last 5 years, Rocket Pharmaceuticals' Return on Equity had a median value of 0.52% in 2022 and averaged 0.53%.
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 200bps in 2021, then tumbled by -2000bps in 2024.
  • Rocket Pharmaceuticals' Return on Equity (Quarter) stood at 0.36% in 2021, then plummeted by -46bps to 0.52% in 2022, then grew by 4bps to 0.5% in 2023, then crashed by -36bps to 0.67% in 2024, then dropped by -10bps to 0.74% in 2025.
  • Its Return on Equity stands at 0.74% for Q3 2025, versus 0.69% for Q2 2025 and 0.61% for Q1 2025.